Murine Retroviral Pseudotype Virus Containing Hepatitis B Virus Large and Small Surface Antigens Confers Specific Tropism for Primary Human Hepatocytes: a Potential Liver-Specific Targeting System

AUTOR(ES)

Sung, Vicky M.-H.

FONTE

American Society for Microbiology

RESUMO

We have developed a system for producing murine leukemia virus (MLV) pseudotyped with human hepatitis B virus (HBV) large (L) and small (S) surface antigens (HBsAg) for targeting primary human hepatocytes. Using the MLV(HBV) pseudotype virus containing a β-galactosidase reporter gene, we demonstrated that this pseudotype virus exhibits strict tropism for primary human hepatocytes, similar to the natural target cell specificity of HBV. It does not infect any of the established tissue culture cell lines, including human hepatoma cell lines (HepG2 and Huh-7), or rat primary hepatocytes. The infectivity of MLV(HBV) for human hepatocytes was inhibited by anti-HBs antibody. The L form of HBsAg was both necessary and sufficient for virus infectivity, but the presence of both L and S forms enhanced the surface expression of HBsAg and thus increased virus production. The middle form of HBsAg was not necessary. This pseudotype virus bypasses the requirement for the liver-specific transcription factors for HBV replication, enabling direct study of HBV tissue tropism conferred by the viral envelope proteins. This virus also offers a potential liver-specific targeting system for gene therapy.

Documentos Relacionados

• Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions.
• A liver-specific nuclear factor interacts with the promoter region of the large surface protein gene of human hepatitis B virus.
• Functional analysis of a liver-specific enhancer of the hepatitis B virus.
• Changes in liver-specific compared to common gene transcription during primary culture of mouse hepatocytes.
• Repression of liver-specific hepatitis B virus enhancer 2 activity by adenovirus E1A proteins.